Collaboration Awards: TRC (Translational Research Collaboration) Full Research Awards


2004 (Cycle 10)

  Top
Breast Cancer Functional Imaging with Optics and MRI
Award: $500,000
Institution: University of California, Irvine Subject Area: Imaging, Biomarkers, & Molecular Pathology
Profiling Enzyme Activities in Human Breast Cancer
Award: $464,906
Institution: Scripps Research Institute Subject Area: Pathogenesis
Differential Optical Mammography
Award: $733,901
Institution: SRI International Subject Area: Imaging, Biomarkers, & Molecular Pathology
Profiling Enzyme Activities in Human Breast Cancer
Award: $400,000
Institution: Stanford University Subject Area: Pathogenesis

2002 (Cycle VIII)

  Top
Breast Stromal Genes Act as Early Markers of Malignancy
Award: $398,072
Institution: Stanford University Subject Area: Imaging, Biomarkers, & Molecular Pathology
Prognostic Value of Ras Activation in Breast Cancer
Award: $498,596
Institution: University of California, San Diego Subject Area: Pathogenesis
Breast Stromal Genes Act as Early Markers of Malignancy
Award: $249,624
Institution: University of California, San Francisco Subject Area: Imaging, Biomarkers, & Molecular Pathology

2001 (Cycle VII)

  Top
Breast CT for Much Earlier Detection of Breast Cancer
Award: $500,000
Institution: University of California, Davis Subject Area: Imaging, Biomarkers, & Molecular Pathology

2000 (Cycle VI)

  Top
MRI for High Risk Breast Cancer Screening and Surveillance
Award: $499,630
Institution: University of California, San Francisco Subject Area: Imaging, Biomarkers, & Molecular Pathology
Targeted Delivery of an Anti-breast Tumor Agent
Award: $684,291
Institution: University of Southern California Subject Area: Innovative Treatments
Non-Invasive Optical Characterization of Breast Physiology
Award: $499,915
Institution: University of California, Irvine Subject Area: Imaging, Biomarkers, & Molecular Pathology
Wnt Signaling in Breast Cancer: Translational Studies
Award: $328,129
Institution: University of California, Irvine Subject Area: Innovative Treatments

1999 (Cycle V)

  Top
Can Molecular Markers Predict Response to Adjuvant Therapy
Award: $260,545
Institution: Kaiser Foundation Research Institute Subject Area: Innovative Treatments
Can Molecular Markers Predict Response to Adjuvant Therapy?
Award: $508,813
Institution: University of Southern California Subject Area: Innovative Treatments

1998 (Cycle IV)

  Top
Risk Notification for Women at High Risk for Breast Cancer
Award: $647,982
Institution: Cancer Prevention Institute of California Subject Area: Sociocultural, Behavioral, and Psychological Issues
Timing of Breast Cancer Surgery, Menstrual Cycle & Prognosis
Award: $506,070
Institution: University of California, San Diego Subject Area: Innovative Treatments
Biologic Determinants of Response to Paclitaxel & Radiation
Award: $595,661
Institution: University of Southern California Subject Area: Innovative Treatments
Biological Determinants of Response to Paclitaxel and Radiat
Award: $0
Institution: Molecular Medicine Research Institute Subject Area: Innovative Treatments
Biological Determinants of Response to Paclitaxel and Radiat
Award: $0
Institution: Molecular Medicine Research Institute Subject Area: Innovative Treatments
Does Mobile Mammography Increase Screening in Older Women?
Award: $0
Institution: University of California, Los Angeles Subject Area: Imaging, Biomarkers, & Molecular Pathology
Does Mobile Mammography Increase Screening in Older Women?
Award: $520,640
Institution: University of California, Los Angeles Subject Area: Imaging, Biomarkers, & Molecular Pathology